Adherence to antiretroviral therapy among HIV-infected prison inmates (Spain)

International Journal of STD and AIDS

Volumn 16, Issue 2, 2005, Pages 133-138

  Soto Blanco, José M ^a   Ruiz Pérez, Isabel ^b   March, Joan C ^b  

^a HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^b ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

Author keywords

Adherence; Antiretroviral therapy; Prison HIV care; Prison inmates

Indexed keywords

ANTIRETROVIRUS AGENT; CANNABIS; METHADONE;

ADULT; ARTICLE; CRIME; DEMOGRAPHY; DRUG USE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATIENT COMPLIANCE; PREDICTION; PRIORITY JOURNAL; PRISONER; QUESTIONNAIRE; SELF REPORT; SOCIAL SUPPORT; SPAIN;

ADULT; ANTI-HIV AGENTS; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MALE; PATIENT COMPLIANCE; PRISONERS;

EID: 14644408762     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/0956462053057503     Document Type: Article

References (30)

1. Conklin TJ, Lincoln T, Flanigan TP. A public health model to connect correctional health care with communities. Am J Public Health 1998;88:1249-50
2. Dixon PS, Flanigan TP, DeBuono BA, et al. Infection with the human immunodeficiency virus in prisoners: meeting the health care challenge. Am J Med 1993;95:629-35
3. Delegación del Gobierno para el Plan Nacional sobre las Drogas (DGPNSD). Observatorio Español sobre Drogas. Informe no. 3. Madrid: Ministerio del Interior, 2000
4. Delegación del Gobierno para el Plan Nacional sobre las Drogas (DGPNSD). Observatorio Español sobre Drogas. Informe no. 4. Madrid: Ministerio del Interior, 2001
5. Stephens TT, Braithwaite R, Cozza S. Knowledge of prophylaxis treatment therapy among HIV-positive prisoners. AIDS Care 1999;11:547-54
6. Rothon DA, Mathias RG, Schechter MT. Prevalence of HIV infection in provincial prisons in British Columbia. CMAJ 1994;151:781-7
7. Baillargeon J, Borucki MJ, Zepeda S, Jenson HB, Leach CT. Antiretroviral prescribing patterns in the Texas prison system. Clin Infect Dis 2000;21:1476-81
8. Mostahari F, Riley E, Selwyn PA, Altice FL. Acceptance and adherence with antiretroviral therapy among HIV-infected women in a correctional facility. J Acquir Immune Defic Syndr Hum Retrovirol 1998;18:341-8
9. Frank L. Prisons and public health: emerging issues in HIV treatment adherence. J Assoc Nurses AIDS Care 1999;10:24-32
10. Edwards S, Tenant-Flowers M, Buggy J, et al. Issues in the management of prisoners infected with HIV-1: the King's College Hospital HIV prison service retrospective cohort study. BMJ 2001;17:398-9
11. Altice FL, Mostashari F, Friedland GH. Trust and acceptance of and adherence to antiretroviral therapy. J Acqiur Immune Defic Syndr Hum Retrovirol 2001;28:47-58
12. Mehta S, Moore RD, Graham NMH. Potential factors affecting adherence with HIV therapy. AIDS 1997;11: 1665-70
13. Griffin MM, Ryan JG, Briscoe VS, Shadle KM. Effects of incarceration on HIV-infected individuals. J Natl Med Assoc 1996;88:639-44
14. Ford PM, Wobeser WL. Health care problems in prisons. CMAJ 2000;162:664-5
15. Kikland LR, Fischl MA, Tashima KT, et al. Response to lamivudine-zidovudine plus abacavir twice daily antiretroviral-naive, incarcerated patient with infection taking directly observed treatment. Clin Infect Dis 2002;15:511-8
16. Gonzalez E, Corella I. Programa de prevención y control de la infection par VIH en el medio penitenciario. Primera edición. Madrid: Ministerio del Interior (Dirección General de Instituciones Penitenciarias) y Ministerio de Sanidad y Consumo (Secretaría del Plan Nacional sobre el SIDA), 2000
17. Morinsky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986;24:67-74
18. Gao X, Nau D. Congruence of three self-report measures of medication adherence among HIV patients. Ann Pharmacother 2000;34:1117-22
19. Salud y Drogas en la Cárcel de Huelva. Concejalía de Asuntos Sociales. Comisionado para la Droga. Escuela Andaluza de Salud Pública, 1999-2000
20. Knobel H, Carmona A, Grau S, Pedro-Botet J, Diez A. Adherence and effectiveness of highly active antiretroviral therapy. Arch Intern Med 1998;158:1953
21. Haubrich RN, Little SJ, Currier JS, et al. The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. AIDS 1999;13: 1099-107
22. Chesney MA, Ickovics J, Hecht FM, Sikipa G, Rabkin J. Adherence: a necessity for successful HIV combination therapy. AIDS 1999;13(Suppl A):S271-8
23. Tseng A. Compliance issues in the treatment of HIV infection. Am J Health Syst Pharm 1998;55:1817-24
24. Catz SL, Kelly JA, Bogart LM, Benotsch EG, McAuliffe TL. Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychol 2000;19:124-33
25. Gordillo V, del Amo J, Soriano V, González-Lahoz J. Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS 1999;13:1763-9
26. Sherer R. Adherence and antiretroviral therapy in injection drug users. JAMA 1998;280:567-8
27. Tuldrá A, Ferrer MJ, Fumaz CR, et al. Monitoring adherence to HIV therapy. Arch Intern Med 1999;159:1376-7
28. Friedland GH, Williams A. Attaining higher goals in HIV treatment: the central importance of adherence. AIDS 1999;13(Suppl 1):S61-72
29. Altice FL, Friedland GH, Coony EL. Nevirapine-induced opiate withdrawal among injecting drug users with HIV infection receiving methadone. AIDS 1999;13:957-62
30. Rainey PM, Friedland G, McCance-Katz EF, et al. Interactions of methadone with didanosine and stavudine. J Aquir Immune Defic Syndr Hum Retrovirol 2000;24:241-8